Methylprednisolone Pulse Therapy: Dosing, Duration, and Safety Guidelines

1. Standard Pulse Dosing and Infusion Parameters

• Administer 500 mg–1 g of methylprednisolone intravenously each day (≈10–20 mg/kg) for 3–5 consecutive days in adult patients weighing ~50 kg; this regimen is effective for a range of autoimmune dermatologic conditions. Infuse each dose over at least 30 minutes to minimize the risk of cardiac arrhythmias and arrest. [1][2]

2. Disease‑Specific Pulse Regimens

2.1 Pemphigus Vulgaris

• Use 250 mg–1 g IV daily for 2–5 days, followed by an oral prednisone taper. [1][2]3

2.2 Lupus Nephritis

• Deliver a total cumulative dose of 500 mg–2.5 g methylprednisolone, divided across the treatment course (e.g., 250 mg–500 mg daily for 2–5 days). [4][5]

2.3 Immune‑Related Adverse Events (Grade 3‑4)

• Initiate systemic steroids at 1–2 mg/kg/day (≈50–100 mg for a 50 kg patient).
• Reserve pulse dosing of 500 mg–1 g for severe, refractory toxicities.
• After pulse completion, taper oral prednisone over 4–6 weeks once clinical improvement is evident. [6][7]8

2.4 Acute Severe Autoimmune Hepatitis

• Start with a low‑dose regimen of 0.5 mg/kg/day (≈25 mg for a 50 kg patient); higher pulse doses are not routinely recommended. [9][10]

3. Post‑Pulse Management

• Transition to oral prednisolone at 0.5–1 mg/kg/day (≈25–50 mg daily) with a gradual taper. [1][2]3
• Consider adding an adjuvant immunosuppressant (e.g., azathioprine or mycophenolate) to facilitate steroid reduction. 5

4. Safety Monitoring and Pitfalls

• Infusion rate: Never administer >500 mg in <10 minutes; rapid infusion is linked to bradycardia and arrhythmias. [1][2]
• Course length: Do not exceed 5 days of initial pulse therapy without reassessment; extending beyond this increases infection risk without added benefit. [1][2]5
• Monitoring: Check blood pressure and blood glucose before and during infusion; monitor for infection signs if therapy exceeds 3 weeks. [11][7]
• Prophylaxis: Provide PCP prophylaxis when total immunosuppression is anticipated for >3 weeks. [5][11]

5. Adjunctive Measures

• Administer a proton‑pump inhibitor for gastrointestinal protection. 10
• Supply calcium and vitamin D supplementation to protect bone health during steroid therapy. 10
• Perform blood‑glucose monitoring due to the risk of steroid‑induced hyperglycemia. 11